SCHEMBL14795331

SCHEMBL14795331

Cc1cccc2[nH]c(=O)c(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c(N)c12

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 19/20 0.86
PDGFRB P09619 17/20 0.86
KDR P35968 17/20 0.86
FLT1 P17948 4/20 0.70
LCK P06239 2/20 0.70
FLT3 P36888 2/20 0.70
MAP4K1 Q92918 2/20 0.70
PLK4 O00444 1/20 0.70
STK25 O00506 1/20 0.70
CIT O14578 1/20 0.70
RIOK3 O14730 1/20 0.70
CHEK1 O14757 1/20 0.70
GAK O14976 1/20 0.70
CHUK O15111 1/20 0.70
MUSK O15146 1/20 0.70
EPHB6 O15197 1/20 0.70
PDPK1 O15530 1/20 0.70
MAP3K13 O43283 1/20 0.70
DAPK3 O43293 1/20 0.70
MAP3K7 O43318 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14795859 0.90 FGFR1 (0.70) FGFR1PDGFRBKDRFLT1LCK
SCHEMBL3379948 0.90 FGFR1 (0.86) FGFR1PDGFRBKDRFLT1LCK
Dovitinib SCHEMBL30567813 0.90 FGFR1 (0.86) FGFR1PDGFRBKDRFLT1LCK
Dovitinib SCHEMBL949705 0.90 FGFR1 (0.86) FGFR1PDGFRBKDRFLT1LCK
Dovitinib SCHEMBL12003201 0.89 FGFR1 (0.85) FGFR1PDGFRBKDRFLT1LCK
SCHEMBL14795876 0.87 FGFR1 (0.68) FGFR1PDGFRBKDRFLT1LCK
SCHEMBL3381227 0.85 FGFR1 (0.85) FGFR1PDGFRBKDRFLT1
SCHEMBL3384622 0.85 FGFR1 (0.70) FGFR1PDGFRBKDRFLT1LCK
SCHEMBL3845013 0.84 FGFR1 (0.88) FGFR1PDGFRBKDRFLT1LCK
Dovitinib SCHEMBL946022 0.83 FGFR1 (0.75) FGFR1PDGFRBKDRFLT1LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2762475-A1 Pharmaceutically acceptable salts of quinolinone compounds and their medical use Novartis Vaccines and Diagnostics, Inc. (US) 2014-08-06 EP disclosed
EP-2573079-A2 Benzimidazole quinolinones and uses thereof Novartis Vaccines and Diagnostics, Inc. (US) 2013-03-27 EP disclosed